In Vivo use of monoclonal antibodies against murine T cell antigens
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 52 (3), 486-506
- https://doi.org/10.1016/0090-1229(89)90162-1
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Effector cells in allelic H-2 class I-incompatible skin graft rejection.The Journal of Experimental Medicine, 1987
- REJECTION OF SKIN GRAFTS AND GENERATION OF CYTOTOXIC T CELLS BY MICE DEPLETED OF L3T4+ CELLSTransplantation, 1986
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- SKIN ALLOGRAFT REJECTION BY L3/t4+ AND LYT-2+ T CELL SUBESTSTransplantation, 1986
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cellsNature, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH MONOCLONAL ANTI-T12 ANTIBODY1,2Transplantation, 1983